Is a complete ETR/HPHA research report available?

No complete published report is available for etr/HPHA (ETR/HPHA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/HPHA (ETR/HPHA)

Deutsche Börse Xetra: ETR/HPHA · EUR

€2.56

+0.01 (+0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/HPHA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	119.3M
Revenue (ttm)	7.4M
Net income (ttm)	-33.1M
EPS (ttm)	-€0.71
Shares out	46.8M
Volume	1,001
Beta	0.77

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.4M
Net income (ttm): -33.1M
EPS (ttm): -€0.71
Market cap: 119.3M

All ETR/HPHA indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

EUR

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	41
Employees Change	-73%
Employees Change Percent	-64.04
Enterprise value	EUR 94.4M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	DE000A11QVV0
Last refreshed	2026-07-29
Market cap	EUR 119.3M
Price	EUR 2.56
Price currency	EUR
Rev Per Employee	181,590.46x
Sector	Healthcare
Sector PE	40.49
Sector PE Fwd	15.2
Sic	2836
Symbol	etr/HPHA
Website	https://heidelberg-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.75%
EV/Sales	12.68x
FCF yield	-20.84%
P/B ratio	-8.39x
P/S ratio	16.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	87.49%
Gross Profit	EUR 6.5M
Gross Profit Growth	77.84%
Gross Profit Growth Q	5,788.61%
Gross Profit Growth3 Y	-1.57%
Gross Profit Growth5 Y	31.98%
Net Income	EUR -33.1M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-424.8%
Profit Per Employee	EUR -807,385
Profitable Quarters	EUR 1
ROA	-42.58
Roa5y	-39.93
ROCE	-93.75
ROE	-1,539.9
Roe5y	-165.6
ROIC	-1,042.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.46%
Cagr15y	-11.69%
Cagr1y	-42.75%
Cagr3y	-11.71%
Cagr5y	-17.99%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	77.97x
Revenue Growth Q	3,566.19x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.12x
Revenue Growth5 Y	2.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.14
Assets	EUR 46.9M
Cash	EUR 24.9M
Current Assets	EUR 37.8M
Current Liabilities	EUR 7.2M
Debt	EUR 45,985
Debt FCF	EUR -0
Equity	EUR -14.2M
Interest Coverage	-11,718.3
Liabilities	EUR 61.1M
Long Term Assets	EUR 9.1M
Long Term Liabilities	EUR 54M
Net Cash	EUR 24.9M
Net Cash By Market Cap	EUR 20.86
Net Cash Growth	-24.89%
Tangible Book Value	EUR -23M
Tangible Book Value Per Share	EUR -0.49
WACC	8.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.29
Inventory Turnover	0.08
Net Working Capital	EUR 5.7M
Quick ratio	3.78
Working Capital	EUR 30.7M
Working Capital Turnover	EUR 0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	54.65%
1Y total return	-42.73%
200-day SMA	2.84
3Y total return	-31.18%
50-day SMA	2.63
50-day SMA vs 200-day SMA	50under200
5Y total return	-62.9%
All Time High	61.16
All Time High Change	-95.81%
All Time High Date	2007-02-06
All Time Low	1.39
All Time Low Change	84.57%
All Time Low Date	2016-08-25
ATR	0.1
Beta	0.77
Beta1y	0.2
Beta2y	0.39
Ch YTD	3.23
High	2.56
High52	4.7
High52 Date	2025-07-29
High52ch	-45.53%
Low	2.56
Low52	2.33
Low52 Date	2025-12-29
Low52ch	9.87%
Ma50ch	-2.51%
Price vs 200-day SMA	-9.89%
RSI	46.84
RSI Monthly	42.58
RSI Weekly	41.86
Sharpe ratio	-1.07x
Sortino ratio	-1.26
Total Return	-0.33%
Tr YTD	3.23
Tr15y	-84.52%
Tr1m	-3.76%
Tr1w	4.07%
Tr3m	-9.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -37.3M
Operating margin	-500.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,966,385%
Net Borrowing	-123,164
Shares Insiders	2.31%
Shares Institutions	0.73%
Shares Out	46,784,317
Shares Qo Q	-3.03%
Shares Yo Y	0.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -24.8M
Adjusted OCF	-24,778,985
Average Volume	3,085.45x
Bv Per Share	-0.3
CAPEX	EUR -62,894
Ch10y	54.5
Ch15y	-84.78
Ch1m	-3.76
Ch1w	4.07
Ch1y	-42.73
Ch3m	-9.54
Ch3y	-31.18
Ch5y	-62.9
Ch6m	-13.51
Change	0.39%
Change From Open	0
Close	2.55
Days Gap	0.39
Depreciation Amortization	405,129
Dollar Volume	2,562.6
Earnings Date	2026-07-15
EBIT	EUR -37.3M
EBITDA	EUR -36.8M
EPS	EUR -0.71
F Score	2
FCF	EUR -24.9M
FCF EV Yield	-26.33x
FCF Per Share	EUR -0.53
Financing CF	17,008,673
Fiscal Year End	November
Founded	1,997
Goodwill	6,111,166
Income Tax	EUR 1.5M
Investing CF	630,253
Is Primary Listing	1
Last Earnings Date	2026-07-15
Last Report Date	2026-05-31
Last Split Date	2017-11-07
Last Split Type	Forward
Ma150	2.81
Ma150ch	-8.86%
Ma20	2.58
Ma20ch	-0.66%
Net CF	-8,324,117
Next Earnings Date	2026-10-09
Open	2.56
Ppne	195,770
Price Date	2026-07-28
Relative Volume	0.29x
Revenue	7,445,209x
SBC By Revenue	-0.29x
Share Based Comp	-21,715
Tax By Revenue	19.82x
Tr6m	-13.51%
Volume	1,001
Z Score	-11.4

ETR/HPHA (ETR/HPHA)

Coverage state: Market snapshot only — no published research

Generate the first ETR/HPHA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/HPHA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/HPHA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/HPHA

Frequently asked questions